Adult patients clinically diagnosed with flu-like illness
Conditions
Interventions
Group A:Abidol Hydrochloride Tablets, 200 mg/time, tid, for 5 days
Group B:Oseltamivir Phosphate Capsules, 75 mg/time, bid, for 5 days
Sponsors
The Second Hospital Of Hebei Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) Signed informed consent; 2) Aged >= 18 years, male or female; 3) Body temperature >= 37.5 degree C, and flu-like symptoms: headache, nasal congestion, sore throat, cough, fatigue, muscle aches, chills/sweating, etc., except for upper respiratory tract infection, there is no other diagnostic basis.
Exclusion criteria
Exclusion criteria: 1) Allergic history and/or severe allergic constitution; 2) severe liver and kidney dysfunction; 3) high possibility of bacterial infection according to signs, symptoms or laboratory tests; 4) beginning to appear pulmonary exudative lesions; 5) researchers believe that the impact of the subject's safety of severe heart disease or a history of clinically significant arrhythmia (according to the ECG or history); 6) the use of influenza vaccine within 12 months; 7) known HIV infection; 8) pregnant or lactating women; 9) researchers believe that not suitable for the group.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time for body temperature to drop to normal and return to normal life and work; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to resolution of flu-like symptoms;Proportion of subjects with influenza-like related complications;Incidence of adverse reactions; | — |
Countries
China
Contacts
Public ContactTian Yingping
The Second Hospital of Hebei Medical University
Outcome results
None listed